Drug maker Eli Lilly on Monday announced promising results from a small study of an experimental Alzheimer’s disease drug called donanemab.
Experimental drug for Alzheimer’s disease shows promise
Drug maker Eli Lilly on Monday announced promising results from a small study of an experimental Alzheimer’s disease drug called donanemab.